Evaluation of monocyte chemotactic responsiveness in uraemic patients undergoing haemodialysis with different dialytic membranes

Cytobios

Volumn 1998, Issue 383, 1998, Pages 171-178

  Ventura, M T ^a   Di Corato, R ^a   Giuliano, G ^a   Matino, M G ^a   Antonaci, S ^a  

^a UNIVERSITY OF BARI MEDICAL SCHOOL   (Italy)

Author keywords

Biocompatible membranes; Haemodialysis; MCP 1; Monocyte chemotaxis; Uraemic patients

Indexed keywords

BIOMATERIAL; MONOCYTE CHEMOTACTIC PROTEIN 1; POLY(METHYL METHACRYLATE);

ADULT; ARTICLE; ARTIFICIAL MEMBRANE; BIOSYNTHESIS; CHRONIC KIDNEY FAILURE; FEMALE; GENETICS; HUMAN; IMMUNOLOGY; IN SITU HYBRIDIZATION; MALE; MIDDLE AGED; MONOCYTE; NEUTROPHIL CHEMOTAXIS; RENAL REPLACEMENT THERAPY; UREMIA;

ADULT; BIOCOMPATIBLE MATERIALS; CHEMOKINE CCL2; CHEMOTAXIS, LEUKOCYTE; FEMALE; HUMANS; IN SITU HYBRIDIZATION; KIDNEY FAILURE, CHRONIC; MALE; MEMBRANES, ARTIFICIAL; MIDDLE AGED; MONOCYTES; POLYMETHYL METHACRYLATE; RENAL DIALYSIS; UREMIA;

EID: 0032222641     PISSN: 00114529     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (24)

1. AKAHOSHI T., Kobayashi N., Hosaka S., Sekiyama N., Wada C. and Kondo H. 1995. In vivo induction of monocyte chemotactic and activating factor in patients with chronic renal failure. Nephrol. Dial. Transplant. 10 2244-9.
2. BETZ M., Haensch G. M., Rauterberg E. W., Bommer J. and Ritz E. 1988. Cuprammonium membranes stimulate interleukin 1 release and arachidonic acid metabolism in monocytes in the absence of complement. Kidney Int. 34 67-73.
3. BINGEL M., Lonnemann G., Koch K. M., Dinarello C. A. and Shaldon S. 1988. Plasma interleukin-1 activity during hemodialysis: the influences of dialysis membranes. Nephron. 50 273-6.
4. BÖYUM A. 1968. Isolation of mononuclear cells and granulocytes from human blood. Scand. J. clin. Invest. 21 (Suppl 97) 77-89.
5. CHEUNG A. K., Parker C. J., Wilcox L. and Janatova J. 1989. Activation of the alternative pathway of complement by cellulosic hemodialysis membranes. Kidney Int. 36 57-65.
6. DAUGIRDAS J. T. 1994. The possible effects of dialyzer membrane on morbidity and mortality. Nephrol. Dial. Transplant. 9 (S2) 145-9.
7. DEPPISCH R., Ritz E., Hanch G. M., Schols M. and Rauterberg E. W. 1994. Bioincompatibility-perspectives in 1993. Kidney Int. 45 (S44) 77-84.
8. DESCAMPS-LATSCHA B. and Herbelin A. 1993. Long-term dialysis and cellular immunity: a critical survey. Kidney Int. 43 (Suppl 41) S135-42.
9. DINARELLO C. A. 1992. Agents provocateurs in hemodialysis? Kidney Int. 41 683-94.
10. HAEFFNER-CAVAILLON N., Cavaillon J. M., Ciancioni C., Backle F., Delons S. and Kazatchine M. D. 1989. In vivo induction of interleukin-1 during hemodialysis. Kidney Int. 35 1212-8.
11. HENDERSON L. W., Koch K. M., Dinarello C. A. and Shaldon S. 1993. Hemodialysis hypotension: the interleukin hypothesis. Blood Purif. 1 3-8.
12. HERBELIN A., Ureña P., Nguyen A. T., Zingraff J. and Descamps-Latscha B. 1991. Elevated circulating levels of interleukin-6 in patients with chronic renal failure. Kidney Int. 39 954-60.
13. JIANG Y., Beller D. I., Frendl G. and Graves D. T. 1992. Monocyte chemoattractant protein-1 regulates adhesion molecule expression and cytokine production in human monocytes. J. Immunol. 148 2423-8.
14. LEONARD E. J. and Yoshimura T. 1990. Human monocyte chemoattractant protein-1 (MCP-1). Immunol. Today 11 97-101.
15. ROLLINS B. J., Walz A. and Baggiolini M. 1991. Recombinant human MCP-1/JE induces chemotaxis, calcium flux, and the respiratory burst in human monocytes. Blood 78 1112-6.
16. RUOSLAHTI E. 1991. Integrins. J. clin. Invest. 87 1-5.
17. SHALDON S., Lonnemann G. and Koch K. M. 1987. Cytokine relevance in biocompatibility. Contrib. Nephrol. 79 227-36.
18. SNYDERMAN R., Altman L. C., Hausman M. S. and Mergenhagen S. E. 1972. Human mononuclear leukocyte chemotaxis: a quantitative assay for humoral and cellular chemotactic factor. J. Immunol. 108 857-60.
19. SPRINGER T. A. 1990. Adhesion receptors of the immune system. Nature 346 425-34.
20. TIELEMANS C. L., Delville J. P. C., Husson C. P., Madhoum P., Lambrechts A. M., Goldmann M. and Vanherweghem J. L. 1993. Adhesion molecules and leukocyte common antigen on monocytes and granulocytes during hemodialysis. Clin. Nephrol. 39 158-65.
21. VALENTE A. J., Graves D. T., Vialle-Valentin C. E., Delgado R. and Schwartz C. J. 1988. Purification of a monocyte chemotactic factor secreted by nonhuman primate vascular cells in culture. Biochemistry 27 4162-8.
22. YOSHIMURA T. N., Yuhki N., Moore S. K., Appella E., Lerman M. I. and Leonard E. J. 1989. Human monocyte chemoattractant protein-1 (MCP-1): full length cloning, expression in mitogen stimulated blood mononuclear leukocyte, and sequence similarity to mouse competence gene JE. FEBS Letters 244 487-93.
23. ZACHARIAE O. C., Anderson A. O., Thompson H. L., Appella E., Mantovani A., Oppenheim J. J. and Matsushima K. 1990. Properties of monocytic chemotactic and activating factor (MCAF) purified from a human fibrosarcoma cell line. J. exp. Med. 171 2177-83.
24. ZAOUI P. and Hakim R. M. 1994. The effect of the dialysis membrane on cytokine release. J. Am. Soc. Nephrol. 4 1771-8.